In this study, we analyzed 118 penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) isolates (MICs, >0.12 g/ml) recovered in Poland in 2003 to 2005 from patients with respiratory tract diseases and invasive infections. Seven different serotypes (14, 9V, 23F, 19F, 6B, 19A, and 6A, in order of descending frequency), seven alleles of the murM gene (murMA, murMB6, and the new murMB12 to -16 alleles), and 31 multilocus sequence types (STs) were observed. The vast majority of the PNSP isolates (90.7%) belonged to the international multiresistant clones, and among these, the Spain 9V -ST156 clonal complex was the most prevalent (56 isolates) and was significantly overrepresented in invasive infections. The clone has been evolving rapidly, as demonstrated by the observed number of STs, the diversity in multiple-locus variable-number-tandem-repeat analysis (MLVA) types, and the polymorphism of pbp and pspA genes (coding for penicillin-binding proteins and the pneumococcal surface protein A, respectively). The presence and structure of the rlrA islet (encoding the pneumococcal pilus) were very well conserved. The Spain 9V -ST156 clonal complex has been largely responsible for a decreasing susceptibility to penicillin among pneumococci in Poland in recent years, in spite of a relatively moderate antimicrobial use.Streptococcus pneumoniae (pneumococcus) is a leading cause of community-acquired respiratory tract infections (RTIs) and one of the major agents of invasive bacterial diseases such as sepsis and meningitis (4). Its diminishing susceptibility to antimicrobials, especially to -lactams (3,13,43,44,46), is of the highest concern. In a clinical isolate, the loss of -lactam susceptibility results from DNA acquisition from a penicillin-nonsusceptible S. pneumoniae (PNSP) strain (11, 23, 51) or a viridans group streptococcus (14). Changes in three of the six pbp genes, encoding the penicillin-binding proteins (PBPs), which are active in peptidoglycan synthesis, are the major resistance factors (56). However, other determinants, such as variants of the murM gene, play a role in resistance expression as well (7,12,19,20).Modern typing methods, mainly multilocus sequence typing (MLST) (1), greatly facilitate tracking the geographic spread of specific S. pneumoniae strains and following the dynamics of microbial populations over time. It was found that relatively few clones, the so-called multiresistant international clones defined by the Pneumococcal Epidemiology Network (PMEN) (34; www.sph.emory.edu/pmen), cause increases in pneumococcal resistance to -lactams and other drugs (29,36,44,47,57). The "epidemiologic success" of a particular S. pneumoniae clone may also arise from factors augmenting its fitness. These would include virulence factors which improve the survival of pneumococci in the human host (24), such as the highly polymorphic pneumococcal surface protein A (PspA) (25), involved in the protection of pneumococci against the host immune system (53). Another factor, a pilus, was recently proposed to contri...